precision medicine

By Dave Muoio May 6, 2019
The NIH’s All of Us Research Program celebrated its one-year anniversary today with new updates on enrollment progress, previews of its upcoming cloud-based data platform for health researchers and the public beta launch of an online tool for viewing aggregated, de-identified information about the program’s enrollees. “I hoped [one year ago] that many would share this vision and help us achieve...
By Dave Muoio May 3, 2019
Awareness of personalized medicine and treatment is slowly, but gradually, on the rise, according to the results of a recent survey polling 1,000 consumers published by automated dosage platform maker Dosis. What’s more, older consumers are the most likely demographic to have some awareness of personalized medicine, as well as the first to admit that their prescriptions are not adequately...
By Dave Muoio April 9, 2019
Concerto HealthAI, the maker of a clinical insight generation platform that employs real-world data in its analyses, is racking up the pharma partnerships as of late. Just weeks after the artificial intelligence company agreed to a multi-year deal with Bristol-Myers Squibb, Concerto announced this morning a similar project with Pfizer that will support the latter’s research on precision oncology...

Moshe Bar Siman-Tov speaks at MedInIsrael 2019 in Tel Aviv. Photo by Roy Habani.

By Jonah Comstock April 1, 2019
With a population of just 9 million, Israel is not a large country. But its contributions to health innovation, in particular digital health, are outsized. The country boasts 500 digital health startups as well as hospitals like Sheba Medical Center, which has recently been ranked in the top 10 in the world by Newsweek. What does the country have going for it? A mostly interoperable, fully...

Prof. Boaz Lerner of Ben-Gurion University with the new platform for predicting ALS progression​. Credit: BGU

By Dean Koh February 19, 2019
BGN Technologies, the technology transfer company of Ben-Gurion University (BGU), today unveiled an artificial intelligence (AI) platform for monitoring and predicting the progression of neurodegenerative diseases for the purpose of identifying markers for personalised patient care and improved drug development. Developed by Prof. Boaz Lerner of the Department of Industrial Engineering and...
By Dave Muoio October 22, 2018
The advent of big data and various connected health devices promise countless advantages to the healthcare industry. As facilitators of the personalized health movement, each represents an opportunity to extend care beyond the doctor’s office and into the realms of genomic insights and social or behavioral influences on health, Dr. Lynda Chin, executive director of real-world education, detection...

Photo by Christopher Huang.

By Dave Muoio October 18, 2018
The NIH’s All of Us Research Program launched in May with a daunting task ahead of it — collecting demographic, health, behavior and genomic data from a 1 million person cohort comprised of demographics often underrepresented in biomedical research. Speaking this morning at the Connected Health Conference in Boston, Dr. Dara Richardson-Heron, All of Us’ chief engagement officer, said that the...
Exterior photo of MIT's CSAIL institute in Stata Center in Boston

MIT's CSAIL institute is located in the Stata Center. Credit: Google Maps

By Mike Miliard August 20, 2018
ReMix, a new technology in the works at MIT's Computer Science and Artificial Intelligence Laboratory, seeks to make progress toward a new paradigm of treatment – one that's less reliant on endoscopy and surgery, but instead relies on sensors and what scientists call an "in-body GPS" to help make diagnoses and guide drug administration. The goal, researchers said, is a new approach to patient...
By Tom Sullivan May 29, 2018
As precision medicine and its related technologies take off in healthcare with rocket-like speed, many players in the space are advocating for a balance between innovation and regulation. Without policies in place, there are major mistakes that hospitals, researchers, clinicians, and policymakers will need to avoid to ensure that the healthcare system remains available to all, according to...
By Mike Miliard October 19, 2017
Genomic sequencing has come a long way in a short time, and its potential to drive even faster innovations in precision medicine is enormous. To capitalize on that opportunity, however, health systems need data – lots of it, from all sorts of people. Kaiser Permanente has been building a biobank with genomic data and other health information from hundreds of thousands of patients from across its...